May 14, 2025 / 01:00PM GMT
Jeff Borcherding - Immunovia AB(publ)-Chief Executive Officer
Thank you very much.
This is Jeff Borcherding, CEO of Immunovia. I'm very excited that you've chosen to join us today and I want to thank those who have taken the time to learn more about Immunovia and our exciting progress over the first quarter.
As we continue on our journey of saving lives through early detection in pancreatic cancer, this first quarter marked an important turning point for the company as we transitioned from product development and a focus on the product and clinical development and transition to a focus on commercialization and preparing to launch our test later on this year.
Before we jump into the presentation, I'd like to share a brief story.
It's about a woman who reached out to me a few weeks ago. She is a young woman in her 40s. She has a family and also has a family history of pancreatic cancer. She lost her mother to pancreatic cancer at a fairly young age. As you can imagine, this has caused quite a bit of anxiety for her as well as for her
Q1 2025 Immunovia AB (publ) Earnings Call Transcript
May 14, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers